TORTUS, a London, UK-based healthtech generative AI startup building a next-generation assistant for doctors, raised $4.2 million in seed funding.
SaaS Investors
The round was led by Khosla Ventures, with participation from Entrepreneur First, former NHS Chair Lord David Prior, and other investors.
Founded in 2004, Khosla Ventures is a venture capital firm based in Menlo Park, California. The firm seeks to invest in companies operating in technology, artificial intelligence, climate, sustainability, enterprise, consumer, fintech, digital health, medtech and diagnostics, therapeutics, and impact sectors.
TORTUS Use of Funds
The company will use the funds to accelerate the development and compliance of the O.S.L.E.R. agent, expand its capabilities, and broaden its adoption in additional hospitals and primary care organizations. TORTUS aims to empower clinicians and improve patient care by reducing administrative burdens.
About TORTUS
Founded in 2022, TORTUS is a company that specializes in developing next-generation AI co-pilot systems, an intelligent computer interface that uses a voice-controlled AI that can use any software tools to perform clinical language tasks. The company's lead product, O.S.L.E.R. (Operating System Leverage in Electronic Records), automates the clinical documentation process for clinicians, including pre-chart summaries, visit notes, lab requests, coding, and more. TORTUS automates clinical documentation for final sign-off by listening to the clinician’s conversation with their patient and seamlessly interacting with any EHR system.
Funding Details
Company: TORTUS AI LIMITED
Raised: $4.2M
Round: Seed Round
Funding Month: February 2024
Lead Investors: Khosla Ventures
Additional Investors: Entrepreneur First, Lord David Prior
Company Website: https://tortus.ai/
Software Category: Healthcare System
Source: https://tech.eu/2024/02/12/tortus-secures-4-2m-seed-funding-for-clinical-documentation-automation/